These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26756901)

  • 1. A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.
    St John EP; Simen BB; Turenchalk GS; Braverman MS; Abbate I; Aerssens J; Bouchez O; Gabriel C; Izopet J; Meixenberger K; Di Giallonardo F; Schlapbach R; Paredes R; Sakwa J; Schmitz-Agheguian GG; Thielen A; Victor M; Metzner KJ; Däumer MP;
    PLoS One; 2016; 11(1):e0146687. PubMed ID: 26756901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
    Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
    J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.
    Stelzl E; Pröll J; Bizon B; Niklas N; Danzer M; Hackl C; Stabentheiner S; Gabriel C; Kessler HH
    J Virol Methods; 2011 Dec; 178(1-2):94-7. PubMed ID: 21907239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission.
    Hauser A; Kuecherer C; Kunz A; Dabrowski PW; Radonić A; Nitsche A; Theuring S; Bannert N; Sewangi J; Mbezi P; Dugange F; Harms G; Meixenberger K
    PLoS One; 2015; 10(10):e0140809. PubMed ID: 26469189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.
    Gantner P; Morand-Joubert L; Sueur C; Raffi F; Fagard C; Lascoux-Combe C; Salmon D; Amiel C; Lambert-Niclot S; Fofana DB; Viard JP; Fafi-Kremer S; Rouzioux C; Avettand-Fenoel V; Ghosn J
    J Antimicrob Chemother; 2016 Mar; 71(3):751-61. PubMed ID: 26676973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.
    Trabaud MA; Icard V; Ramière C; Tardy JC; Scholtes C; André P
    J Med Virol; 2017 Nov; 89(11):1912-1919. PubMed ID: 28590068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism.
    Jeanne N; Saliou A; Carcenac R; Lefebvre C; Dubois M; Cazabat M; Nicot F; Loiseau C; Raymond S; Izopet J; Delobel P
    Sci Rep; 2015 Nov; 5():16944. PubMed ID: 26585833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.
    Gibson RM; Meyer AM; Winner D; Archer J; Feyertag F; Ruiz-Mateos E; Leal M; Robertson DL; Schmotzer CL; Quiñones-Mateu ME
    Antimicrob Agents Chemother; 2014; 58(4):2167-85. PubMed ID: 24468782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing.
    Alteri C; Santoro MM; Abbate I; Rozera G; Bruselles A; Bartolini B; Gori C; Forbici F; Orchi N; Tozzi V; Palamara G; Antinori A; Narciso P; Girardi E; Svicher V; Ceccherini-Silberstein F; Capobianchi MR; Perno CF
    J Antimicrob Chemother; 2011 Nov; 66(11):2615-23. PubMed ID: 21890537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Automatic Analysis of Ultradeep Pyrosequencing Raw Data to Determine Percentages of HIV Resistance Mutations in Patients Followed-Up in Hospital.
    Bellecave P; Recordon-Pinson P; Fleury H
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):85-92. PubMed ID: 26529549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Roche prototype 454 HIV-1 ultradeep sequencing drug resistance assay in a routine diagnostic laboratory.
    Garcia-Diaz A; Guerrero-Ramos A; McCormick AL; Macartney M; Conibear T; Johnson MA; Haque T; Webster DP
    J Clin Virol; 2013 Oct; 58(2):468-73. PubMed ID: 23954217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.
    Eshleman SH; Crutcher G; Petrauskene O; Kunstman K; Cunningham SP; Trevino C; Davis C; Kennedy J; Fairman J; Foley B; Kop J
    J Clin Microbiol; 2005 Feb; 43(2):813-7. PubMed ID: 15695685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
    Nicot F; Jeanne N; Raymond S; Delfour O; Carcenac R; Lefebvre C; Sauné K; Delobel P; Izopet J
    J Med Virol; 2018 Sep; 90(9):1486-1492. PubMed ID: 29750364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 nucleotide mixture detection in the virco(®)TYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencing.
    De Wolf H; Van Marck H; Mostmans W; Thys K; Vandenbroucke I; Van Eygen V; Pattery T; Verhasselt P; Aerssens J
    J Virol Methods; 2011 Jul; 175(1):129-32. PubMed ID: 21549149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure.
    Mohamed S; Penaranda G; Gonzalez D; Camus C; Khiri H; Boulmé R; Sayada C; Philibert P; Olive D; Halfon P
    AIDS; 2014 Jun; 28(9):1315-24. PubMed ID: 24698843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of low-level HIV-1 variants with reverse transcriptase mutation K65R and the effect of antiretroviral drug exposure on variant levels.
    Kozal MJ; Chiarella J; St John EP; Moreno EA; Simen BB; Arnold TE; Lataillade M
    Antivir Ther; 2011; 16(6):925-9. PubMed ID: 21900725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing does not reveal additional transmitted mutations in patients diagnosed with HIV-1 variants with single nucleoside reverse transcriptase inhibitor resistance mutations.
    Pingen M; van der Ende ME; Wensing AM; el Barzouhi A; Simen BB; Schutten M; Boucher CA
    HIV Med; 2013 Mar; 14(3):176-81. PubMed ID: 22989004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations.
    Johnson JA; Li JF; Wei X; Lipscomb J; Bennett D; Brant A; Cong ME; Spira T; Shafer RW; Heneine W
    PLoS One; 2007 Jul; 2(7):e638. PubMed ID: 17653265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
    Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance.
    Ji H; Li Y; Graham M; Liang BB; Pilon R; Tyson S; Peters G; Tyler S; Merks H; Bertagnolio S; Soto-Ramirez L; Sandstrom P; Brooks J
    Antivir Ther; 2011; 16(6):871-8. PubMed ID: 21900719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.